Improving the prevention, diagnosis, treatment and prognosis of HFpEF.
The Shah Lab
Heart failure with preserved ejection fraction (HFpEF) accounts for more than 50 percent of all heart failure cases and is associated with high morbidity and mortality. HFpEF prevalence is increasing with the aging population and the ongoing epidemics of obesity, diabetes and hypertension. HFpEF is under-recognized, diagnosis can be challenging and there are few proven therapies for HFpEF. Therefore, in 2007, Sanjiv Shah, MD, started the world's first dedicated clinical program for HFpEF at Northwestern University Feinberg School of Medicine with the goal of improving the prevention, diagnosis, treatment and prognosis of HFpEF.
Updates From the Lab